MX388149B - Dispositivo para administracion transdermal de buprenorfina. - Google Patents

Dispositivo para administracion transdermal de buprenorfina.

Info

Publication number
MX388149B
MX388149B MX2018004246A MX2018004246A MX388149B MX 388149 B MX388149 B MX 388149B MX 2018004246 A MX2018004246 A MX 2018004246A MX 2018004246 A MX2018004246 A MX 2018004246A MX 388149 B MX388149 B MX 388149B
Authority
MX
Mexico
Prior art keywords
buprenorphine
transdermal delivery
adhesive matrix
adhesive
acrylic polymer
Prior art date
Application number
MX2018004246A
Other languages
English (en)
Other versions
MX2018004246A (es
Inventor
Alejandro Fabio Scasso
Francisco José Evaristo Stefano
Original Assignee
Amarin Tech S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amarin Tech S A filed Critical Amarin Tech S A
Publication of MX2018004246A publication Critical patent/MX2018004246A/es
Publication of MX388149B publication Critical patent/MX388149B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un dispositivo para la administración transdermal de buprenorfina que comprende una matriz adhesiva, una lámina de soporte y una lámina de despegue, en donde la matriz adhesiva comprende un polímero acrílico adhesivo no entrecruzado y sin funcionalidad carboxílica, Buprenorfina Base, ácido levulínico y Miristato de isopropilo.
MX2018004246A 2015-10-08 2016-10-07 Dispositivo para administracion transdermal de buprenorfina. MX388149B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ARP150103253A AR102214A1 (es) 2015-10-08 2015-10-08 Un dispositivo para la administración transdermal de buprenorfina
PCT/EP2016/074072 WO2017060472A1 (en) 2015-10-08 2016-10-07 A device for the transdermal delivery of buprenorphine

Publications (2)

Publication Number Publication Date
MX2018004246A MX2018004246A (es) 2018-06-27
MX388149B true MX388149B (es) 2025-03-19

Family

ID=58487101

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018004246A MX388149B (es) 2015-10-08 2016-10-07 Dispositivo para administracion transdermal de buprenorfina.

Country Status (6)

Country Link
US (1) US20190117585A1 (es)
EP (1) EP3359143B1 (es)
AR (1) AR102214A1 (es)
CA (1) CA3000891A1 (es)
MX (1) MX388149B (es)
WO (1) WO2017060472A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230390214A1 (en) * 2020-08-19 2023-12-07 Toyo Ink Sc Holdings Co., Ltd. Adhesive patch

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4446600A1 (de) 1994-12-24 1996-06-27 Lohmann Therapie Syst Lts Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen
DE102006054731B4 (de) * 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
CN103200944B (zh) * 2010-11-17 2016-05-04 赫克萨尔股份公司 包含丁丙诺啡的经皮治疗系统
EP2919767B1 (en) * 2012-11-14 2020-04-01 Abon Pharmaceuticals, LLC Oral transmucosal drug delivery system
DE112014002664T5 (de) * 2013-06-04 2016-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales Verabreichungssystem

Also Published As

Publication number Publication date
EP3359143B1 (en) 2025-07-23
EP3359143A1 (en) 2018-08-15
US20190117585A1 (en) 2019-04-25
CA3000891A1 (en) 2017-04-13
EP3359143C0 (en) 2025-07-23
WO2017060472A1 (en) 2017-04-13
MX2018004246A (es) 2018-06-27
AR102214A1 (es) 2017-02-15

Similar Documents

Publication Publication Date Title
CR20150647A (es) Sistema de liberación transdérmica
EP3377972A4 (en) Device management system, apparatus and method for notification and scheduling of firmware update
TW201611859A (en) Microneedle device
MX2017003623A (es) Parche de opipramol.
EP3873494A4 (en) Biodegradable microneedles for transdermal therapeutic agent delivery
UA114101C2 (xx) Трансдермальна терапевтична система для введення фентанілу або його аналога
EP3664885A4 (en) TRANSDERMAL DRUG DELIVERY SYSTEM
BR112017028520A2 (pt) Sistemas adesivo de laminação - poliéster- policarbonato-poliol
AR095258A1 (es) Composiciones transdérmicas de metilfenidato con adhesivos a base de goma
AR094289A1 (es) Sistemas de administracion transdermica de farmacos para levonorgestrel y etinil estradiol
MX2019001104A (es) Sistemas de suministro transdermico de memantina.
CY1123202T1 (el) Σκευασμα υδροκορτιζονης ελεγχομενης απελευθερωσης
CY1123720T1 (el) Συνθεσεις ενος πολυορθοεστερα και ενος εκδοχου οργανικου οξεος
EP3880175A4 (en) TEMPERATURE-REGULATING TRANSDERMAL DRUG DELIVERY SYSTEM
PH12016501469B1 (en) Ketoprofen-containing poultice
MX2020003662A (es) Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende un polimero hibrido acrilico de silicona.
MX2020003665A (es) Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende por lo menos un aditivo.
MX2020003667A (es) Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende un polimero de silicona.
DK3549374T3 (da) Kommunikations- og sporingssystem til lægemiddelindgiftsanordninger til engangsbrug
BR112017001764A2 (pt) método, e, aparelho
EP3456711A4 (en) CASPASE INHIBITOR AND PHARMACEUTICAL COMPOSITION, USE AND THERAPEUTIC METHOD THEREFOR
EP3012574B8 (de) Einrichtung zur steuerbaren druckentlastung eines wirksystems
EA201790855A1 (ru) Трансдермальная терапевтическая система с высокой адгезивной способностью
MX388149B (es) Dispositivo para administracion transdermal de buprenorfina.
CO2017010782A2 (es) Aditivos sin silicona en materiales de revestimiento de liberación